# 4D pharma plc (LBPS)

Source: https://www.quantisnow.com/company/LBPS
Generated: 2026-11-10T11:07:16.417Z

- Ticker: LBPS
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: https://www.4dpharmaplc.com

## About

4D pharma plc, together with its subsidiaries, develops live biotherapeutic products (LBPs) in the United Kingdom. The company develops therapeutic candidates, including MRx0518 for the treatment of cancer and immune-oncology diseases; MRx-4DP0004 for the treatment of asthma; MRx0029 and MRx0005 the treatment of central nervous system disorders; Blautix for irritable bowel syndrome; and Thetanix for pediatric crohn's disease. It also develops products candidates, such as MRx1299 for solid tumors, MRx0006 for rheumatoid arthritis, and MRx0002 for multiple sclerosis. In addition, the company develops MicroRx platform to discover new LBP candidates for major diseases. 4D pharma plc has a collaboration agreement with Merck KGaA, Darmstadt, Germany and Pfizer to evaluate MRx0518; strategic collaboration agreement with University of Texas MD Anderson for discovery and development of LBPs in oncology; and Merck & Co., Inc. to conduct a clinical trial evaluating the combination of Keytruda, MRx0518 in patients with solid tumors, and to discover and develop LBPs for vaccines. The company was formerly known as Schosween 18 Limited. 4D pharma plc was incorporated in 2014 and is headquartered in Leeds, the United Kingdom.

## Latest LBPS news and filings

- 2023-01-03 17:09 UTC [SEC Form 6-K] [SEC Form 6-K filed by 4D pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-4d-pharma-plc-3863441)
- 2022-11-18 19:58 UTC [SEC Form 6-K] [SEC Form 6-K filed by 4D pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-4d-pharma-plc-3709418)
- 2022-11-15 18:53 UTC [SEC Form 6-K] [SEC Form 6-K filed by 4D pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-4d-pharma-plc-3690583)
- 2022-10-07 14:58 UTC [SEC Form 6-K] [SEC Form 6-K filed by 4D pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-4d-pharma-plc-3507765)
- 2022-09-30 19:04 UTC [SEC Form 6-K] [SEC Form 6-K filed by 4D pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-4d-pharma-plc-3478500)
- 2022-08-24 21:06 UTC [SEC Form 6-K] [SEC Form 6-K filed by 4D pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-4d-pharma-plc-3329661)
- 2022-08-24 20:56 UTC [SEC Form 6-K] [SEC Form 6-K filed by 4D pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-4d-pharma-plc-3329580)
- 2022-08-24 20:43 UTC [SEC Form 6-K] [SEC Form 6-K filed by 4D pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-4d-pharma-plc-3329471)
- 2022-07-19 15:48 UTC [SEC Form 25-NSE filed by 4D pharma plc](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-4d-pharma-plc-3158456)
- 2022-07-05 18:06 UTC [SEC Form 6-K] [SEC Form 6-K filed by 4D pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-4d-pharma-plc-3106705)
- 2022-06-29 18:25 UTC [SEC Form 6-K] [SEC Form 6-K filed by 4D pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-4d-pharma-plc-3090022)
- 2022-06-28 17:50 UTC [4D pharma plc ("4D pharma") Receives Notice of Delisting From Nasdaq](https://www.quantisnow.com/insight/4d-pharma-plc-4d-pharma-receives-notice-of-delisting-from-3082895)
- 2022-06-27 14:06 UTC [Market Insight] [Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2022](https://www.quantisnow.com/insight/benzingas-top-ratings-upgrades-downgrades-for-june-27-2022-3074136)
- 2022-06-27 12:34 UTC [Market Chatter] [Chardan Capital Downgrades 4d pharma to Neutral](https://www.quantisnow.com/insight/chardan-capital-downgrades-4d-pharma-to-neutral-3073318)
- 2022-06-24 21:19 UTC [SEC Form 6-K] [SEC Form 6-K filed by 4D pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-4d-pharma-plc-3071096)
- 2022-06-24 18:41 UTC [Update on Suspension of Trading](https://www.quantisnow.com/insight/update-on-suspension-of-trading-3069813)
- 2022-06-24 13:19 UTC [SEC Form 6-K] [SEC Form 6-K filed by 4D pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-4d-pharma-plc-3067724)
- 2022-06-23 08:25 UTC [Market Insight] [76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More](https://www.quantisnow.com/insight/76-biggest-movers-from-yesterday-ocean-bio-chem-athira-pharma-and-3060350)
- 2022-06-22 17:43 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-intraday-session-3058060)
- 2022-06-22 16:30 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Wednesday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-wednesday-3057795)
- 2022-06-22 16:17 UTC [Market Insight] [40 Stocks Moving In Wednesday's Mid-Day Session](https://www.quantisnow.com/insight/40-stocks-moving-in-wednesdays-mid-day-session-3057715)
- 2022-06-22 12:06 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-pre-market-session-3055877)
- 2022-06-22 08:49 UTC [Market Insight] [67 Biggest Movers From Yesterday](https://www.quantisnow.com/insight/67-biggest-movers-from-yesterday-3054742)
- 2022-06-21 16:03 UTC [Market Insight] [45 Stocks Moving In Tuesday's Mid-Day Session](https://www.quantisnow.com/insight/45-stocks-moving-in-tuesdays-mid-day-session-3051745)
- 2022-06-13 16:18 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Monday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-monday-3020882)
- 2022-06-10 15:45 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Friday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-friday-3015100)
- 2022-06-01 19:31 UTC [SEC Form 6-K] [SEC Form 6-K filed by 4D pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-4d-pharma-plc-2974647)
- 2022-05-26 21:30 UTC [4D pharma Presents Trial in Progress Poster on Study of MRx0518 in Combination with BAVENCIO® in Patients with Unresectable Locally Advanced or Metastatic Urothelial Carcinoma at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting](https://www.quantisnow.com/insight/4d-pharma-presents-trial-in-progress-poster-on-study-of-2953151)
- 2022-05-19 20:30 UTC [Conference Announcement] [4D pharma to Present at the H.C. Wainwright Global Investment Conference](https://www.quantisnow.com/insight/4d-pharma-to-present-at-the-hc-wainwright-global-investment-2918319)
- 2022-05-17 11:00 UTC [4D pharma Presents Late Breaking Abstract from Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma at the American Thoracic Society (ATS) 2022 International Conference](https://www.quantisnow.com/insight/4d-pharma-presents-late-breaking-abstract-from-phase-iii-trial-2899492)
- 2022-05-05 10:18 UTC [Market Insight] [24 Stocks Moving in Thursday's Pre-Market Session](https://www.quantisnow.com/insight/24-stocks-moving-in-thursdays-pre-market-session-2832988)
- 2022-04-29 12:16 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-pre-market-session-2796304)
- 2022-04-29 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by 4D pharma plc](https://www.quantisnow.com/insight/sec-form-effect-filed-by-4d-pharma-plc-2795147)
- 2022-04-21 21:31 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-after-market-session-2752681)
- 2022-04-21 20:29 UTC [SEC Form F-3 filed by 4D pharma plc](https://www.quantisnow.com/insight/sec-form-f-3-filed-by-4d-pharma-plc-2751995)
- 2022-04-04 16:33 UTC [SEC Form 6-K] [SEC Form 6-K filed by 4D pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-4d-pharma-plc-2671836)
- 2022-04-04 08:59 UTC [Market Insight] [55 Biggest Movers From Friday](https://www.quantisnow.com/insight/55-biggest-movers-from-friday-2668414)
- 2022-04-01 20:44 UTC [SEC Form S-8] [SEC Form S-8 filed by 4D pharma plc](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-4d-pharma-plc-2666837)
- 2022-04-01 16:56 UTC [Market Insight] [38 Stocks Moving In Friday's Mid-Day Session](https://www.quantisnow.com/insight/38-stocks-moving-in-fridays-mid-day-session-2664848)
- 2022-04-01 13:11 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-pre-market-session-2663327)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/LBPS
- Earnings history: https://www.quantisnow.com/earnings/LBPS
- Dividend history: https://www.quantisnow.com/dividends/LBPS
- Insider transactions: https://www.quantisnow.com/insiders/LBPS
- Options chain: https://www.quantisnow.com/options/LBPS
- SEC 8-K filings only: https://www.quantisnow.com/company/LBPS/8-k
- RSS and alerts for LBPS: https://www.quantisnow.com/docs/rss-feeds.md